Improving Clinical and Economic Outcomes in Hyperkalemia: Managed Care Considerations for Pharmacy Professionals

Gain expert insights on the management of hyperkalemia, including the appropriate use of oral potassium binders, to improve clinical and economic outcomes.
Katherine Di Palo, PharmD
Michelle Richardson, PharmD, BCPS
Format: Microsoft PowerPoint (.ppt)
File Size: 1.87 MB
Released: April 11, 2022

Acknowledgements

Provided by ProCE, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Related Content

Dr. Katherine Di Palo discusses use of novel potassium binders for the management of hyperkalemia, from ProCE

Katherine Di Palo, PharmD Released: May 13, 2022

Expert faculty provide practical strategies for successful management of hyperkalemia from ProCE

Katherine Di Palo, PharmD Michelle Richardson, PharmD, BCPS Pharmacists: 1.5 contact hours (0.15 CEUs) Released: May 12, 2022 Expired: May 11, 2023

Downloadable slides featuring expert insights on engaging patients and the healthcare team in collaborative, shared decision-making from ProCE.

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

Concise microlearning module featuring expert insight on the use of DOAC therapy in NVAF for stroke prevention from ProCE

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 13, 2022 Expired: April 12, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings